68Ga PET/CT Versus 99mTc SPECT/CT for Lung Perfusion and Ventilation Scintigraphy; a Technical and Practical Feasibility Study

Launched by UMC UTRECHT · Jan 29, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new imaging technique called 68Ga PET/CT to see if it can effectively replace the traditional 99mTc SPECT/CT method for assessing lung function and detecting pulmonary embolisms (PE), which are blockages in the lungs. The goal is to determine if this new technique is just as good or better than the current standard, especially since 68Ga PET/CT may help overcome some challenges associated with the older method. This study could lead to a more efficient and safer way to diagnose lung issues for certain patients.

To be eligible for this trial, participants must be adults aged 18 or older who are referred for a conventional lung scan due to suspected PE and can provide informed consent. However, pregnant individuals cannot participate. If you join the study, you can expect to undergo tests that will help researchers gather important information about the new imaging technique and its feasibility. This study is currently recruiting participants, and your involvement could contribute to advancements in lung health diagnostics.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult ≥18 years and declared competent
• • Provided written informed consent
• • Referred to the Nuclear Medicine Department for a conventional V/Q-SPECT/CT
• • Indication for conventional V/Q-SPECT/CT includes known or suspected pulmonary embolism
• Exclusion Criteria:
• • - Pregnancy